5-Aza-2′-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression

International Journal of Cancer

Volumn 129, Issue 9, 2011, Pages 2083-2092

  Couillard, Julie ^a   Estève, Pierre Olivier ^b   Pradhan, Sriharsa ^b   St Pierre, Yves ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b NEW ENGLAND BIOLABS   (United States)

Author keywords

DNA methylation; gene expression; IL 1; matrix metalloproteinase; MMP 3

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CCAAT ENHANCER BINDING PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN C JUN; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MMP3 GENE; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

AZACITIDINE; COLONIC NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HCT116 CELLS; HELA CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 80052269426     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25865     Document Type: Article

References (42)

1. Pender SL, Croucher PJ, Mascheretti S, Prothero JD, Fisher SA, MacDonald TT, Schreiber S, Ye S,. Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease. J Med Genet 2004; 41: e112.
2. Zhang Y, Gong LH, Zhang HQ, Du Q, You JF, Tian XX, Fang WG,. Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 2010; 293: 189-97.
3. Nieminen R, Korhonen R, Moilanen T, Clark AR, Moilanen E,. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs. Arthritis Rheum 2010; 62: 1650-9.
4. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA,. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007; 75: 813-20. (Pubitemid 47238734)
5. Auble DT, Brinckerhoff CE,. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 1991; 30: 4629-35.
6. Hui A, Min WX, Tang J, Cruz TF,. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum 1998; 41: 869-76. (Pubitemid 28225788)
7. Armstrong DA, Phelps LN, Vincenti MP,. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells. Mol Cancer Res 2009; 7: 1517-24.
8. Chicoine E, Esteve PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y,. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun 2002; 297: 765-72. (Pubitemid 35230316)
9. Couillard J, Demers M, Lavoie G, St-Pierre Y,. The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem Biophys Res Commun 2006; 342: 1233-9.
10. Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA,. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 2006; 66: 9202-10. (Pubitemid 44521141)
11. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, Kokubun S, Bronner F,. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005; 52: 3110-24. (Pubitemid 41447092)
12. Sato N, Maehara N, Su GH, Goggins M,. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J Natl Cancer Inst 2003; 95: 327-30.
13. Clark IM, Swingler TE, Sampieri CL, Edwards DR,. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008; 40: 1362-78.
14. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-28. (Pubitemid 34587077)
15. Baillat D, Begue A, Stehelin D, Aumercier M,. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J Biol Chem 2002; 277: 29386-98. (Pubitemid 41079222)
16. Pedersen G, Saermark T, Kirkegaard T, Brynskov J,. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium. Clin Exp Immunol 2009; 155: 257-65.
17. Di Sabatino A, Jackson CL, Pickard KM, Buckley M, Rovedatti L, Leakey NA, Picariello L, Cazzola P, Monteleone G, Tonelli F, Corazza GR, MacDonald TT, et al. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 2009; 58: 777-89.
18. Quinones S, Saus J, Otani Y, Harris ED, Jr, Kurkinen M,. Transcriptional regulation of human stromelysin. J Biol Chem 1989; 264: 8339-44. (Pubitemid 19137325)
19. Yan C, Boyd DD,. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 211: 19-26. (Pubitemid 46363892)
20. Westermarck J, Seth A, Kahari VM,. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 1997; 14: 2651-60. (Pubitemid 27283104)
21. Westermarck J, Kahari VM,. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-92. (Pubitemid 29220691)
22. Hayashida M, Okazaki K, Fukushi J, Sakamoto A, Iwamoto Y,. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis. Arthritis Rheum 2009; 60: 708-16.
23. Luo D, Guerin E, Ludwig MG, Stoll I, Basset P, Anglard P,. Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site. J Biol Chem 1999; 274: 37177-85.
24. Tao L, Yang S, Xie M, Kramer PM, Pereira MA,. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett 2000; 158: 185-93.
25. Jaenisch R, Bird A,. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33: 245-54. (Pubitemid 36278835)
26. Ma DK, Jang MH, Guo JU, Kitabatake Y, Chang ML, Pow-Anpongkul N, Flavell RA, Lu B, Ming GL, Song H,. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009; 323: 1074-7.
27. Engel N, Tront JS, Erinle T, Nguyen N, Latham KE, Sapienza C, Hoffman B, Liebermann DA,. Conserved DNA methylation in Gadd45a(-/-) mice. Epigenetics 2009; 4: 98-9.
28. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI,. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 2009; 60: 3303-13.
29. Stresemann C, Lyko F,. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer 2008; 123: 8-13. (Pubitemid 351705186)
30. Luszczek W, Cheriyath V, Mekhail TM, Borden EC,. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Mol Cancer Ther 2010; 9: 2309-21.
31. Freund A, Orjalo AV, Desprez PY, Campisi J,. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16: 238-46.
32. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C,. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007; 128: 83-91. (Pubitemid 46073064)
33. Davalos AR, Coppe JP, Campisi J, Desprez PY,. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 2010; 29: 273-83.
34. Fumagalli M, d'Adda di Fagagna F,. SASPense and DDRama in cancer and ageing. Nat Cell Biol 2009; 11: 921-3.
35. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G,. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16: 859-67.
36. Atadja P, Wong H, Garkavtsev I, Veillette C, Riabowol K,. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8348-52.
37. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC,. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996; 93: 13742-7. (Pubitemid 26424190)
38. Narita M,. Cellular senescence and chromatin organisation. Br J Cancer 2007; 96: 686-91. (Pubitemid 46376638)
39. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, Ellerton J, Larson RA, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002; 20: 2429-40. (Pubitemid 34525728)
40. Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R, III, Shen L, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106: 1794-803.
41. Egeblad M, Werb Z,. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74. (Pubitemid 37328786)
42. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C,. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003; 35: 252-7. (Pubitemid 37363179)